Projects

Ing. Monika Buríková, PhD.

International

Current
  • Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer
    Program: ERANET
    Duration: 1. 9. 2024 – 31. 8. 2027

National

Current
  • Evaluation of the role of tumor microenvironment stromal component in breast cancer treatment outcome using an organoid model
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Exosomes secreted by cancer cells of digestive organs, their characterization and modification by the CRISPR/Cas9 system for the aim of use in therapy
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Development of patients derived xenografts models and their utilization for personalized treatment of uveal melanoma
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Unraveling the role of genetic predispositions in the context of breast cancer tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Markers overlapping chemoresistance and metastatic potential in colorectal cancer - aldehyde dehydrogenase and its clinical relevance
    Program: Other projects
    Duration: 1. 11. 2019 – 31. 12. 2022
  • The dynamics of inflammation-induced epigenetic changes during epithelial-to-mesenchymal transition and their role in human pancreatic ductal adenocarcinoma progression
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Identifikacion of a molecular mechanism inducing appearance of dormant cell population in multiple myeloma
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2018
Employees